Expression of Matrix Metalloproteinases in Intraductal Papillary Mucinous Neoplasm of the Pancreas

Anticancer Res. 2019 Aug;39(8):4485-4490. doi: 10.21873/anticanres.13623.

Abstract

Background/aim: Intraductal papillary mucinous neoplasm (IPMN) has a variety of histological and morphological appearances. Matrix metalloproteinases (MMPs) have been considered to be associated with tumor progression or poor prognosis. The aim of this study was to elucidate the molecular basis of IPMN variation in different types of lesions.

Materials and methods: The expression of MMP-1,2,7,9 in 51 cases of IPMN were investigated. The MMP score was calculated as the sum of the score of staining distribution and the score of the intensity staining.

Results: MMP scores were correlated with histological grade, histological subtype, and type of invasion. MMP high expression groups (MMP score ≥5) had worse prognosis than low-expression groups.

Conclusion: MMP expression varied between different types of IPMN, a result supporting differences in molecular basis of malignancies. These considerations may be helpful for optimal management or treatment according to various types of IPMN.

Keywords: Intraductal papillary mucinous neoplasm; histological grade; histological subtype; immunohistochemistry; matrix metalloproteinases; type of invasion.

MeSH terms

  • Aged
  • Disease-Free Survival
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Male
  • Matrix Metalloproteinase 1 / genetics*
  • Matrix Metalloproteinase 2 / genetics*
  • Matrix Metalloproteinase 7 / genetics*
  • Matrix Metalloproteinase 9 / genetics*
  • Middle Aged
  • Pancreas / metabolism
  • Pancreas / pathology
  • Pancreatic Intraductal Neoplasms / epidemiology
  • Pancreatic Intraductal Neoplasms / genetics*
  • Pancreatic Intraductal Neoplasms / pathology

Substances

  • MMP7 protein, human
  • Matrix Metalloproteinase 7
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Matrix Metalloproteinase 1